德視佳(01846.HK)哥本哈根新旗艦診所料明年初開始營運
德視佳(01846.HK)公佈,位於哥本哈根的新旗艦診所已於今年8月開始施工,建設工程已初步完成,預計將於明年1月正式竣工,並計劃於明年初開始營運。
集團指,新旗艦眼科診所位於帕肯體育場,該場地爲2021年歐洲盃足球賽的12個主辦比賽的場地之一,新旗艦眼科診所將取代現有場地,其中一個手術室將面向哥本哈根(帕肯)主體育館的賽事場地,旨在進一步鞏固德視佳在北歐地區視力矯正行業的領先地位。
德視佳的創始人,董事長兼首席執行官約根森表示,新旗艦診所位於市中心黃金地段,規模較大,將完美配合集團在丹麥的現有診所網絡,認爲集團在哥本哈根的業務擴張與該地區的服務需求相互呼應,未來將密切留意市場,積極把握因視力保健意識持續提高帶來的商機,會繼續探索理想地點以建立新診所,同時進一步提高集團現有手術中心的利用率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.